<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-5-42-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-5-6-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurocutaneous Syndromes</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Von Hippel-Lindau Disease: Familial Symptom Clusters</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>1991</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>5</volume>
<issue>6</issue>
<fpage>42</fpage>
<lpage>43</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1991 The Author(s)</copyright-statement>
<copyright-year>1991</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/0140-6736(91)91705-Y" vol="337" page="1052">
<article-title>Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The clinical manifestations and prevalence of von Hippel-Lindau syndrome (HLS) were reported from the Department of Medicine, Albert-Ludwigs-Universitat, Freiburg im Breisgau, Germany, and Department of Pathology, University of Zurich, Switzerland.</p>
</abstract>
<kwd-group>
<kwd>Hippel-Lindau Syndrome</kwd>
<kwd>Phaeochromocytoma</kwd>
<kwd>Epididymal Cystadenoma</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The clinical manifestations and prevalence of von Hippel-Lindau syndrome (HLS) were reported from the Department of Medicine, Albert-Ludwigs-Universitat, Freiburg im Breisgau, Germany, and Department of Pathology, University of Zurich, Switzerland. A striking familial clustering of HLS lesions was discovered: angiomatosis retinae in 51% (47/92), haemangioblastoma of the CNS in 46% (42/92), renal lesions in 33% (30/92) and phaeochromocytoma in 24% (22/92). Of the 92 patients, 52 had 1, 31 had 2, and 9 had 3 of the 4 HLS lesions. Of 29 evaluated kindreds, 18 had renal lesions. Some features of HLS were frequently combined whereas others seemed to be almost exclusive. The patterns of lesions within individual kindreds were stable. Vascular lesions of the syndrome (angiomatosis retinae and haemangioblastoma of the CNS) occurred in most families and represented core features whereas phaeochromocytoma at one end of the scale, and renal lesions, pancreatic cysts and epididymal cystadenoma at the other end of the scale, were unlikely to develop in the same family and were mutually exclusive. The authors suggest that HLS is caused from different mutations within a complex genetic locus, or additional genetic lesions, which cooperate with the HLS gene on chromosome 3p. The data point to a linear sequence of features. The calculated prevalence of the disease in the district of Freiburg, Germany, with a population of 1.909 million, was 1/38951. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><underline>COMMENT</underline>. These familial patterns of lesions are important in prognosis and the clinical management of HLS gene carriers. Patients with renal lesions are at a high risk for hemangioblastoma of the CNS, the principal cause of death in HLS patients. Patients presenting with renal disorders should be carefully monitored for the development of CNS lesions. Patients with pheochromocytoma are likely to develop angiomatosis retinae but are usually spared the CNS complication.</p>
<p>Von Hippel-Lindau disease has been associated with loss of a region of chromosome 3 that is often deleted in renal cell carcinoma. This region contains a tumor suppressor gene whose absence is associated with the development of renal cell carcinoma, hemangioblastoma and other tumors of von Hippel-Lindau disease. Deletion of the tumor suppressor gene may allow ectopic production of erythropoietin by the intracranial hemangioblastoma. Production of erythropoietin by a recurrent intracranial hemangioblastoma in a 59 year old woman was thought to explain the erythrocytosis in this patient with von Hippel-Lindau disease. [<xref ref-type="bibr" rid="CIT0002">2</xref>]</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Wiestler</surname>
<given-names>OD</given-names>
</name>
</person-group>
<article-title>Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus</article-title>
<source>Lancet</source>
<year>1991</year>
<month>May</month>
<day>4</day>
<volume>337</volume>
<issue>8749</issue>
<fpage>1052</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">1673491</pub-id>
<pub-id pub-id-type="doi">10.1016/0140-6736(91)91705-Y</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horton</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Harsh</surname>
<given-names>GR</given-names>
<suffix>4th</suffix>
</name>
<name>
<surname>Fisher</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Hoyt</surname>
<given-names>WF</given-names>
</name>
</person-group>
<article-title>Von Hippel-Lindau disease and erythrocytosis: radioimmunoassay of erythropoietin in cyst fluid from a brainstem hemangioblastoma</article-title>
<source>Neurology</source>
<year>1991</year>
<month>May</month>
<volume>41</volume>
<issue>5</issue>
<fpage>753</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">2027498</pub-id>
<pub-id pub-id-type="doi">10.1212/WNL.41.5.753</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
